IL18 and ovarian cancer: Relatedly, anti-inflammatory evidence of withaferin A has been shown in ovarian cancer cells by suppressing the secretion levels of various pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNFα), IL-6, IL-8, and IL-18 in ovarian cancer cells [108].